文献速递糖尿病

2000-23年全球糖尿病照护级联的系统综述与建模分析

Global, regional, and national cascades of diabetes care, 2000-23: a systematic review and modelling analysis using findings from the Global Burden of Disease Study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2025-09-09

该研究基于全球疾病负担研究数据,采用系统综述与贝叶斯建模分析2000至2023年204个国家的糖尿病照护级联。尽管二十年来诊断和治疗比例有所提升,但诊断不足和血糖管理不佳仍是全球重大挑战,中低收入国家尤为突出。

核心结论

  • 尽管过去二十年有所改善,糖尿病诊断不足和血糖管理不佳仍是全球主要挑战,中低收入国家尤为突出。
  • 需要加强策略和能力建设以改善全球糖尿病的发现、治疗和管理。

研究设计与样本

  • 利用全球疾病负担研究(GBD)数据和方法开展的建模分析,覆盖2000至2023年204个国家和地区。
  • 系统综述一般人群代表性横断面调查及已发表和灰色文献,采用DisMod-MR 2.1贝叶斯meta回归建模工具按地点、年份、年龄和性别分别建模。

关键数值与推荐

  • 治疗定义为当前使用胰岛素或其他降糖药物。
  • 照护级联指标包括:糖尿病患者中诊断比例、确诊患者中治疗比例、治疗患者中理想血糖比例。
  • 区域差异:诊断率最高在高收入北美,确诊者治疗率最高在高收入亚太,治疗者理想血糖率最高在拉丁美洲南部。

临床怎么用

  • 应加强糖尿病检测、治疗和管理策略及能力建设,尤其在中低收入国家。
  • 针对性干预以提升卫生系统有效诊断和管理糖尿病的能力,可改善健康结局并减轻疾病负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetes is a serious global health challenge, with a rising prevalence and substantial effect on disability and mortality worldwide. Despite medical advancements, gaps in the cascade of diabetes care-comprising diagnosis, treatment, and glycaemic management-persist, hindering effective management. We aimed to comprehensively assess the state of the diabetes cascade of care globally, identifying areas of strength and needs for improvement in diabetes management. METHODS: Using data and methods from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), this modelling analysis spanned the years 2000 to 2023 and covered 204 countries and territories. We systematically reviewed cross-sectional surveys that are representative of the general population and the published and grey literature to estimate the proportion of people with diabetes who are undiagnosed, diagnosed but untreated, receiving treatment with suboptimal glycaemic concentrations, and receiving treatment with optimal glycaemic concentrations. Treatment was defined as current use of insulin or other hypoglycaemic medication. We separately modelled these quantities by location, year, age, and sex using DisMod-MR 2.1, a hierarchical Bayesian meta-regression modelling tool, then scaled the estimates so that they sum to 100% of people living with diabetes in each stratum. Using GBD 2023 estimates of the number of people with diabetes, we calculated the diabetes cascade of care: proportion of people diagnosed among those with diabetes, proportion of people receiving treatment among those with diagnosed diabetes, and proportion of people with optimal glycaemic concentrations among those receiving treatment for diabetes across all strata. FINDINGS: In 2023, an estimated 55·8% (95% UI 49·3-62·3) of people with diabetes aged 15 years and older were diagnosed with diabetes globally. The proportion of people with diagnosed diabetes who were on treatment was 91·4% (88·0-94·2), and the proportion of people on diabetes treatment with optimal glycaemic concentrations was 41·6% (35·7-48·5). Among all people with diabetes, the proportion with optimal glycaemic concentrations on treatment was 21·2% (17·4-25·6) in 2023 globally. Substantial regional differences were observed, with the highest rates of diagnosis in high-income North America, the highest rates of treatment among those with diagnosed diabetes in high-income Asia Pacific, and the highest rates of optimal glycaemic concentrations among those receiving treatment for diabetes in southern Latin America. Between 2000 and 2023, globally, the proportion of people diagnosed with diabetes increased by 8·3 (6·6-10·0) percentage points, and the proportion of people receiving treatment among those diagnosed increased by 7·2 (5·7-8·8) percentage points. The proportion of people receiving treatment who had optimal glycaemic concentrations increased by 1·3 (0·8-1·8) percentage points. INTERPRETATION: Despite improvements over the past two decades, underdiagnosis and suboptimal glycaemic management of diabetes remain major challenges globally, particularly in low-income and middle-income countries. These findings highlight the urgent need for enhanced strategies and capacity building to improve the detection, treatment, and management of diabetes worldwide. Targeted interventions to bolster health-care systems' capacity to effectively diagnose and manage diabetes could lead to better health outcomes and reduce the burden of this growing disease. FUNDING: Bill & Melinda Gates Foundation.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Stafford LK, Gage A, Xu YY, et al. Global, regional, and national cascades of diabetes care, 2000-23: a systematic review and modelling analysis using findings from the Global Burden of Disease Study. Lancet Diabetes Endocrinol. 2025. PMID: 40934935. doi:10.1016/S2213-8587(25)00217-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。